Get the Stockscreener App
1.5664
3.95%
0.0595
Cocrystal Pharma Inc stock is traded at $1.5664, with a volume of 37,859.
It is up +3.95% in the last 24 hours and down -2.10% over the past month.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
See More
Previous Close:
$1.5069
Open:
$1.52
24h Volume:
37,859
Relative Volume:
0.57
Market Cap:
$16.07M
Revenue:
-
Net Income/Loss:
$-17.93M
P/E Ratio:
-0.885
EPS:
-1.77
Net Cash Flow:
$-14.28M
1W Performance:
-7.59%
1M Performance:
-2.10%
6M Performance:
-19.67%
1Y Performance:
-17.12%
1-Day Range:
$1.51
$1.63
1-Week Range:
$1.45
$1.70
52-Week Range:
$1.12
$3.26
Cocrystal Pharma Inc Stock (COCP) Company Profile
Name
Cocrystal Pharma Inc
Sector
Industry
Phone
(786) 459-1831
Address
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.5664 | 15.87M | 0 | -17.93M | -14.28M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-20 | Initiated | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Stock (COCP) Latest News
Full technical analysis of Cocrystal Pharma Inc. stock2025 Volatility Report & Real-Time Market Trend Scan - Newser
Will Cocrystal Pharma Inc. stock go up soonBond Market & Accurate Buy Signal Alerts - Newser
Is Cocrystal Pharma Inc. forming a bottoming baseBuy Signal & Free Community Supported Trade Ideas - Newser
Long term hold vs stop loss in Cocrystal Pharma Inc.Quarterly Profit Review & Verified Momentum Watchlists - Newser
How to track smart money flows in Cocrystal Pharma Inc.Market Volume Summary & AI Driven Stock Movement Reports - Newser
Will a bounce in Cocrystal Pharma Inc. offer an exitMarket Sentiment Report & High Accuracy Swing Trade Signals - Newser
Cocrystal Pharma Inc. Added to High Probability Setup List2025 AllTime Highs & Fast Exit and Entry Trade Guides - classian.co.kr
COCP: Norovirus Challenge Study to Initiate in 4Q25… - Zacks Small Cap Research
Cocrystal Pharma Inc. stock outlook for YEAR2025 Market Overview & High Accuracy Swing Entry Alerts - Newser
Does Cocrystal Pharma Inc. fit your quant trading modelWeekly Trend Recap & Technical Analysis for Trade Confirmation - Newser
What data driven models say about Cocrystal Pharma Inc.’s futureInsider Buying & Daily Entry Point Trade Alerts - Newser
Syndax Pharmaceuticals (NASDAQ:SNDX) and Cocrystal Pharma (NASDAQ:COCP) Head-To-Head Comparison - Defense World
Cocrystal Pharma Inc. stock daily chart insightsDay Trade & Verified Entry Point Detection - Newser
Detecting support and resistance levels for Cocrystal Pharma Inc.Weekly Profit Recap & Weekly Breakout Watchlists - Newser
Price momentum metrics for Cocrystal Pharma Inc. explainedJuly 2025 Final Week & Reliable Momentum Entry Alerts - Newser
Applying sector rotation models to Cocrystal Pharma Inc.2025 Retail Activity & Safe Entry Point Alerts - Newser
What dividend growth rate does Cocrystal Pharma Inc. offerProfit Target & AI Forecasted Entry/Exit Points - sundaytimes.kr
Will Cocrystal Pharma Inc. stock recover after recent drop2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser
Chart based analysis of Cocrystal Pharma Inc. trendsSwing Trade & Weekly Hot Stock Watchlists - Newser
What indicators show strength in Cocrystal Pharma Inc.July 2025 Setups & AI Enhanced Trading Signals - Newser
How to interpret RSI for Cocrystal Pharma Inc. stock2025 Pullback Review & Fast Entry High Yield Stock Tips - Newser
Using AI based signals to follow Cocrystal Pharma Inc.CEO Change & Smart Money Movement Alerts - Newser
Is Cocrystal Pharma Inc. a stock for growth or value investorsQuarterly Earnings Report & Reliable Price Breakout Alerts - newsimpact.co.kr
Cocrystal Pharma Reports Second Quarter 2025 Financial Results - TradingView
Cocrystal Pharma Reports Second Quarter 2025 Financial - GlobeNewswire
Cocrystal Pharma Reports Second Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs - Yahoo Finance
Is ContextLogic Inc. forming a bullish divergence2025 Short Interest & Real-Time Volume Analysis Alerts - newsyoung.net
Is Destiny Tech100 Inc. reversing from oversold territoryRisk Management & Weekly Setup with High ROI Potential - Newser
NexPoint Residential Trust Inc. stock volume spike explainedJuly 2025 WrapUp & Low Volatility Stock Suggestions - Newser
What machine learning models say about Cocrystal Pharma Inc.July 2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
Key resistance and support levels for ESS Tech Inc.Index Update & Risk Controlled Daily Trade Plans - Newser
Applying chart zones and confluence areas to Cyclacel Pharmaceuticals Inc. [July 2025 Earnings]Free Fast Exit Strategy with Risk Control - Newser
Using data tools to time your Movano Inc. exitTrade Entry Report & Consistent Profit Alerts - Newser
How to build a custom watchlist for Biodesix Inc.Real-Time AI Sentiment and Price Forecast - Newser
Predicting PLAYSTUDIOS Inc. trend using moving averagesForecast Model for Intraday Buy Signals - Newser
Why Jiuzi Holdings Inc. stock attracts strong analyst attentionEntry Optimization Tool with Screener Logic - Newser
Decker Inc.Breakout Watcher with Entry and Exit Alerts - Newser
Backtesting results for Rithm Capital Corp. trading strategiesReal Market Tracker with Price Action Tools - Newser
Cocrystal Pharma Inc Stock (COCP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):